StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3067% below fair value
$0.71+0.08 (+12.14%)

Close on Nov 18, 2026Market cap $5.36MP/E –Yield –

Cerenome operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Cerenome's operating income for the twelve months ending Jun 30, 2026 was -$26.40M. For fiscal 2025 it was -$15.30M. The highest annual figure on record is -$3.66M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.30M–
FY2024Dec 31, 2024-$14.70M–
FY2023Dec 31, 2023-$13.32M–
FY2022Dec 31, 2022-$19.71M–
FY2021Dec 31, 2021-$12.49M–
FY2020Dec 31, 2020-$9.58M–
FY2019Dec 31, 2019-$3.66M–
FY2018Dec 31, 2018-$8.76M–
FY2017Dec 31, 2017-$20.68M–
FY2016Dec 31, 2016-$19.71M–
FY2015Dec 31, 2015-$15.29M–
FY2014Dec 31, 2014-$32.44M–
FY2013Dec 31, 2013-$30.68M–
FY2012Dec 31, 2012-$28.42M–
FY2011Dec 31, 2011-$29.41M–
FY2010Dec 31, 2010-$25.32M–
FY2009Dec 31, 2009-$21.55M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.06M–
Q1 FY2026Mar 31, 2026-$7.12M–
Q4 FY2025Dec 31, 2025-$5.74M–
Q3 FY2025Sep 30, 2025-$4.48M–
Q2 FY2025Jun 30, 2025-$1.54M–
Q1 FY2025Mar 31, 2025-$3.54M–
Q4 FY2024Dec 31, 2024-$3.90M–
Q3 FY2024Sep 30, 2024-$3.80M–
Q2 FY2024Jun 30, 2024-$3.70M–
Q1 FY2024Mar 31, 2024-$3.30M–
Q4 FY2023Dec 31, 2023-$3.86M–
Q3 FY2023Sep 30, 2023-$3.25M–
Q2 FY2023Jun 30, 2023-$1.49M–
Q1 FY2023Mar 31, 2023-$4.72M–
Q4 FY2022Dec 31, 2022-$5.57M–
Q3 FY2022Sep 30, 2022-$5.09M–
Q2 FY2022Jun 30, 2022-$5.12M–
Q1 FY2022Mar 31, 2022-$3.93M–
Q4 FY2021Dec 31, 2021-$3.94M–
Q3 FY2021Sep 30, 2021-$3.50M–
Q2 FY2021Jun 30, 2021-$2.58M–
Q1 FY2021Mar 31, 2021-$2.48M–
Q4 FY2020Dec 31, 2020-$3.40M–
Q3 FY2020Sep 30, 2020-$1.40M-152.1%
Q2 FY2020Jun 30, 2020-$2.35M–
Q1 FY2020Mar 31, 2020-$2.44M–
Q4 FY2019Dec 31, 2019-$2.21M–
Q3 FY2019Sep 30, 2019$2.68M–
Q2 FY2019Jun 30, 2019-$1.96M–
Q1 FY2019Mar 31, 2019-$2.17M–
Q4 FY2018Dec 31, 2018-$1.91M–
Q1 FY2018Mar 31, 2018-$4.35M–
Q4 FY2017Dec 31, 2017-$3.63M–
Q3 FY2017Sep 30, 2017-$4.34M–
Q2 FY2017Jun 30, 2017-$5.58M–
Q1 FY2017Mar 31, 2017-$7.13M–
Q4 FY2016Dec 31, 2016-$3.59M–
Q3 FY2016Sep 30, 2016-$4.80M–
Q2 FY2016Jun 30, 2016-$6.22M–

More Cerenome figures

See a number that looks wrong?